These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12792559)

  • 1. The cholecystokinin antagonist proglumide enhances the analgesic effect of dihydrocodeine.
    McCleane GJ
    Clin J Pain; 2003; 19(3):200-1. PubMed ID: 12792559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cholecystokinin antagonist proglumide enhances the analgesic efficacy of morphine in humans with chronic benign pain.
    McCleane GJ
    Anesth Analg; 1998 Nov; 87(5):1117-20. PubMed ID: 9806692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of systemic morphine analgesia in humans by proglumide, a cholecystokinin antagonist.
    Price DD; von der Gruen A; Miller J; Rafii A; Price C
    Anesth Analg; 1985 Aug; 64(8):801-6. PubMed ID: 4014744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proglumide as a morphine adjunct in cancer pain management.
    Bernstein ZP; Yucht S; Battista E; Lema M; Spaulding MB
    J Pain Symptom Manage; 1998 May; 15(5):314-20. PubMed ID: 9654837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia.
    Benedetti F
    Pain; 1996 Mar; 64(3):535-543. PubMed ID: 8783319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study.
    Frank B; Serpell MG; Hughes J; Matthews JN; Kapur D
    BMJ; 2008 Jan; 336(7637):199-201. PubMed ID: 18182416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of nocebo hyperalgesia by the cholecystokinin antagonist proglumide.
    Benedetti F; Amanzio M; Casadio C; Oliaro A; Maggi G
    Pain; 1997 Jun; 71(2):135-40. PubMed ID: 9211474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of morphine analgesia by the cholecystokinin antagonist proglumide.
    Watkins LR; Kinscheck IB; Mayer DJ
    Brain Res; 1985 Feb; 327(1-2):169-80. PubMed ID: 3838690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and tolerability of controlled-release dihydrocodeine tablets and combination dextropropoxyphene/paracetamol tablets in patients with severe osteoarthritis of the hips.
    Lloyd RS; Costello F; Eves MJ; James IG; Miller AJ
    Curr Med Res Opin; 1992; 13(1):37-48. PubMed ID: 1468244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placebo-controlled, double-blind study of the effects of proglumide in the treatment of schizophrenia.
    Whiteford HA; Stedman TJ; Welham J; Csernansky JG; Pond SM
    J Clin Psychopharmacol; 1992 Oct; 12(5):337-40. PubMed ID: 1362205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zomepirac, dihydrocodeine and placebo compared in postoperative pain after day-case surgery. The relationship between the effects of single and multiple doses.
    McQuay HJ; Bullingham RE; Moore RA; Carroll D; Evans PJ; O'Sullivan G; Collin J; Lloyd JW
    Br J Anaesth; 1985 Apr; 57(4):412-9. PubMed ID: 3986070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of proglumide, a cholecystokinin antagonist, to potentiate clinical morphine analgesia. A randomized double-blind postoperative study using patient-controlled analgesia (PCA).
    Lehmann KA; Schlüsener M; Arabatsis P
    Anesth Analg; 1989 Jan; 68(1):51-6. PubMed ID: 2642668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Parkinson's disease with proglumide, a CCK antagonist.
    Piolti R; Appollonio I; Cocco E; Ferrarese C; Frattola L; Rovati L; Panerai AE
    Neurology; 1991 May; 41(5):749-50. PubMed ID: 2027496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The visceral and somatic antinociceptive effects of dihydrocodeine and its metabolite, dihydromorphine. A cross-over study with extensive and quinidine-induced poor metabolizers.
    Wilder-Smith CH; Hufschmid E; Thormann W
    Br J Clin Pharmacol; 1998 Jun; 45(6):575-81. PubMed ID: 9663813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydrocodeine: safety concerns.
    Leppert W; Woroń J
    Expert Rev Clin Pharmacol; 2016; 9(1):9-12. PubMed ID: 26479786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of dihydrocodeine and dihydromorphine to analgesia following dihydrocodeine administration in man: a PK-PD modelling analysis.
    Webb JA; Rostami-Hodjegan A; Abdul-Manap R; Hofmann U; Mikus G; Kamali F
    Br J Clin Pharmacol; 2001 Jul; 52(1):35-43. PubMed ID: 11453888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cholecystokinin antagonist proglumide has an analgesic effect in chronic pancreatitis.
    McCleane GJ
    Pancreas; 2000 Oct; 21(3):324-5. PubMed ID: 11039479
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination hydrocodone and ibuprofen versus combination codeine and acetaminophen for the treatment of chronic pain.
    Palangio M; Damask MJ; Morris E; Doyle RT; Jiang JG; Landau CJ; de Padova A
    Clin Ther; 2000 Jul; 22(7):879-92. PubMed ID: 10945514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomised, double blind, placebo controlled crossover study of the cholecystokinin 2 antagonist L-365,260 as an adjunct to strong opioids in chronic human neuropathic pain.
    McCleane GJ
    Neurosci Lett; 2003 Feb; 338(2):151-4. PubMed ID: 12566175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rofecoxib versus codeine/acetaminophen in postoperative dental pain: a double-blind, randomized, placebo- and active comparator-controlled clinical trial.
    Chang DJ; Fricke JR; Bird SR; Bohidar NR; Dobbins TW; Geba GP
    Clin Ther; 2001 Sep; 23(9):1446-55. PubMed ID: 11589259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.